ArticleSkin health and disease2026
Trial of food allergy IgE tests for Eczema Relief (TIGER): study protocol.
Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Background: Food allergy may contribute to eczema, but there is variability in the use of tests to investigate this, and uncertainty about possible benefits or harms. The objective is to determine the clinical and cost-effectiveness of test-guided dietary advice compared with standard care for eczema management. Methods: This is a pragmatic, multicentre, parallel group, individually randomized controlled trial with internal pilot and nested genetic substudy and economic and process evaluations. Children (aged 3 months to <2 years) were recruited via general practitioner surgeries in England and randomized 1:1 to standard care or intervention. Both groups received a 'Good eczema care' leaflet. The intervention group also received dietary advice for cow's milk, hen's eggs, wheat and soya, based on skin prick tests and dietary history. Discussion: The primary outcome is parent-reported eczema control [RECap for AtoPic eczema (RECAP)], completed 4-weekly over 24 weeks. Secondary outcomes include eczema symptoms; quality of life; adverse events; breastfeeding status and diet; growth; and parental anxiety. The primary analysis is a multilevel mixed model framework with observations over time nested within participants. A cost-utility analysis will compare quality-adjusted life years for the child and main carer to costs incurred by the National Health Service (NHS) between groups. Additionally, costs from NHS and non-NHS perspectives will be related to a range of outcomes in a cost-consequences approach. A nested process evaluation will assess intervention fidelity, clarify causal mechanisms and identify contextual factors associated with variation in outcomes. This trial will fill an evidence gap of clinical importance and reduce variation in practice and associated harms. Protocol registration: The protocol is registred with ISRCTN (ISRCTN52892540): https://www.isrctn.com/ISRCTN52892540.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.